
GHRH/GHRP combination for synergistic growth hormone research
This product is coming soon. Join the waitlist to be notified when it's available.
These products are intended for laboratory research use only and are not for human consumption. Not for use in food, drug, household, or cosmetic applications. All research should be conducted in accordance with applicable safety guidelines and regulations.
This blend combines CJC-1295 (a GHRH analogue) with Ipamorelin (a ghrelin receptor agonist) in a single vial. Research into the combination leverages their complementary mechanisms — pituitary GHRH receptor activation alongside ghrelin receptor stimulation — to study synergistic growth hormone axis modulation.
Combination GH secretagogue research with CJC-1295 and Ipamorelin has characterized their synergistic amplification of GH pulse amplitude, with studies noting that GHRH and GHRP co-administration produces GH release exceeding either compound alone.
Store lyophilized at -20°C, tightly sealed, away from heat, light and moisture. Once reconstituted, refrigerate at 2-8°C and use within 28 days.
Reconstitute with bacteriostatic water for multi-dose use (supports the 28-day refrigerated window), or an appropriate sterile diluent per your research protocol. Allow the vial to reach room temperature before reconstitution.
Stable for 18-36 months when stored lyophilized at -20°C or below, sealed and protected from light and moisture. Once reconstituted, use within 28 days refrigerated at 2-8°C.
For Research Use Only — Not for Human or Animal Consumption. This is a general laboratory dilution calculator (mass-to-volume concentration math) for in vitro research planning. It is not medical guidance, not a dosing tool, and not intended to support administration to humans or animals. All Nuvopeptide products are sold exclusively for in vitro laboratory research and have not been evaluated by the FDA.